CareDx, Inc (CDNA) compared with its closest peers (CSTL, FLGT, BLLN, VCYT, CAI): P/E 22.3 vs industry 25.4. Peer set by Healthcare Services; 10 comparable companies. First-party data.
Castle Biosciences, Fulgent Genetics, BillionToOne, Veracyte, Caris Life Sciences, Lumexa Imaging Holdings, Inc. Common Stock, GRAIL, Guardant Health, Biodesix and RadNet share CareDx's sub-industry, medical laboratories.
| Company | Market Cap | P/E |
|---|---|---|
| Castle Biosciences, Inc. (CSTL) | $1.07B | -46.9 |
| Fulgent Genetics, Inc. (FLGT) | $548.38M | -13.3 |
| BillionToOne, Inc. (BLLN) | $5.45B | 172.9 |
| Veracyte, Inc. (VCYT) | $3.52B | 30.7 |
| Caris Life Sciences, Inc. (CAI) | $7.91B | -8.4 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.13B | 656.4 |
| GRAIL, Inc. (GRAL) | $3.54B | -7.7 |
| Guardant Health, Inc. (GH) | $22.13B | -30.8 |
| Biodesix, Inc. (BDSX) | $294.06M | -1.5 |
| RadNet, Inc. (RDNT) | $6.05B | -285.0 |
| Stock P/E | 22.3 |
| Sector P/E (Healthcare) | 21.9 |
| Industry P/E (Healthcare Services) | 25.4 |
| vs Sector | 1.6% |
| vs Industry | -12.3% |
CDNA overview · CDNA earnings · CDNA financials · CDNA KPIs · CDNA documents · CDNA ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.